Article
Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs - Nature Communications
Rating:
0.0
Views:
53
Likes:
1
Library:
1
There is a clinical need for conceptually new treatments that target the excessive activation of inflammatory pathways during systemic infection. Thrombin-derived C-terminal peptides (TCPs) are endogenous anti-infective immunomodulators interfering with CD14-mediated TLR-dependent immune responses.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value